62 filings
Page 3 of 4
8-K
3dvx r3fq
11 Jan 21
Harpoon Therapeutics Announces Closing of Public Offering of Common Stock
4:18pm
8-K
hbi049f
7 Jan 21
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
4:20pm
8-K
vz8gdm dubf
4 Jan 21
T Cell Engager for Treatment of Small Cell Lung Cancer and other
4:00pm
8-K
cuf6mazpela526
11 Dec 20
Other Events
5:06pm
8-K
jip3sju
9 Dec 20
Harpoon Therapeutics Reports Clinical Progress Across All Four TriTACĀ® Pipeline Development Programs
4:52pm
8-K
v2ul7p6
4 Nov 20
Harpoon Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:15pm
8-K
x57apw
5 Aug 20
Harpoon Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
4:12pm
8-K
268derbvpu796e4
2 Jul 20
Departure of Directors or Certain Officers
9:17am
8-K
lx496e7pn2dzab 3q9wt
1 Jun 20
Submission of Matters to a Vote of Security Holders
4:09pm
8-K
k3t2n49n5wqhzoao6 il
29 May 20
Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose
4:03pm
8-K
nr5hf5k5uuxbmmqy
6 May 20
Harpoon Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
4:10pm
8-K/A
8m3gi 9lcmh8f
17 Apr 20
Departure of Directors or Certain Officers
5:15pm
8-K
v1bolgsy kys3buvw
6 Apr 20
Other Events
6:12am
8-K
p7z 16y0tq
1 Apr 20
Departure of Directors or Certain Officers
5:01pm
8-K
n36nh
12 Mar 20
Harpoon Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Corporate Update
4:11pm
8-K
rhi61k
27 Dec 19
Entry into a Material Definitive Agreement
12:00am
8-K
69yugp2
20 Nov 19
Entry into a Material Definitive Agreement
9:56pm
8-K
spwkciun9e2oe6n0 dm3
6 Nov 19
Harpoon Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
4:15pm
8-K
y1fj9
5 Aug 19
Harpoon Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:15pm
8-K
665rxps zo4rpjle
9 May 19
Harpoon Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
9:00am